With the open letter published in EJNMMI Radiopharmacy and Chemistry by an international working group of experts, the EJNMMI journal family endorses the application of the guidelines in contributions to the journals.
Attached to the letter by the working group is a three-page summary highlighting the most relevant issues in the notation of radiopharmaceuticals and related terms.
The full paper with all recommendations is published in the article BConsensus nomenclature rules for radiopharmaceutical chemistry-setting the record straight Coenen, H.H., Gee A.D. et al., Nuclear Medicine and Biology, Vol. 55, pages v-xi (2017) (https://doi.org/10.1016/j.nucmedbio.2017.09.004)."
All editors-in chief of the EJNMMI journals strongly recommend that all manuscripts meet these guidelines upon submission. In addition, all reviewers will be asked to be aware of the guidelines and, wherever possible, to check whether the guidelines are followed.
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